FCX News Alert Freeport-Mcmoran Inc. (FCX) 26.43 12/04/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Freeport-Mcmoran Inc. (FCX) 26.43 $FCX

Freeport McMoRan announces Gulf drill results, to review oil and gas capex
Seeking Alpha - at Seeking Alpha - Thu Dec 04, 10:15AM CST

FCX: 26.43 (-0.27)

Freeport-McMoRan Announces Positive Drilling Results at the Holstein Deep and Dorado Development Projects in the Gulf of Mexico
Business Wire - Thu Dec 04, 7:01AM CST
Freeport-McMoRan Inc. (NYSE: FCX) announced today positive drilling results from the Freeport-McMoRan Oil & Gas (FM O&G) 100-percent-owned Holstein Deep and Dorado development wells in the Deepwater Gulf of Mexico (GOM). Production from these projects is expected to total approximately 30,000 barrels of oil equivalents (BOE) per day in 2016.
FCX: 26.43 (-0.27)

Goldman: Freeport McMoRan could cut capex and/or dividends to reduce debt
Seeking Alpha - at Seeking Alpha - Wed Dec 03, 11:58AM CST

FCX: 26.43 (-0.27)

After Yesterday's Decline of 2.42%, Freeport-McMoRan Offers Investors Better Value
Comtex SmarTrend(R) - Mon Dec 01, 4:07PM CST
Freeport-McMoRan (NYSE:FCX) traded in a range yesterday that spanned from a low of $25.50 to a high of $26.75. Yesterday, the shares fell 2.4%, which took the trading range below the 3-day low of $26.64 on volume of 21.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
FCX: 26.43 (-0.27)

Watch for Freeport-McMoRan to Potentially Rebound After Falling 2.42% Yesterday
Comtex SmarTrend(R) - Mon Dec 01, 4:06PM CST
Freeport-McMoRan (NYSE:FCX) traded in a range yesterday that spanned from a low of $25.50 to a high of $26.75. Yesterday, the shares fell 2.4%, which took the trading range below the 3-day low of $26.64 on volume of 21.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
FCX: 26.43 (-0.27)

Freeport-McMoRan (FCX) Stock Is Sinking As It Nears $100 Million Settlement
at The Street - Mon Dec 01, 9:32AM CST
Freeport-McMoRan (FCX) stock is down this morning, as the company nears a $100 million settlement to resolve allegations by its shareholders over two acquisitions.
FCX: 26.43 (-0.27)

Next Support Level for Freeport-McMoRan (FCX) is $26.22
Comtex SmarTrend(R) - Mon Dec 01, 9:06AM CST
Shares of Freeport-McMoRan (NYSE:FCX) have bearishly opened below the pivot of $26.96 today and have reached the first support level of $26.53. Analysts will be watching for a cross of the next downside pivot targets of $26.22 and $25.48.
FCX: 26.43 (-0.27)

Freeport McMoRan nears settlement over McMoRan, Plains deals
Seeking Alpha - at Seeking Alpha - Mon Dec 01, 7:24AM CST

FCX: 26.43 (-0.27)

Freeport-McMoRan Crashes As Commodities Tumble: Here's The Real Impact
ColoradoWealthManagementFund - Seeking Alpha - Mon Dec 01, 12:53AM CST
If you're an investor watching the underlying fundamentals in Freeport- McMoRan (NYSE: FCX ), you may be challenged with constantly trying to separate the noise from the fundamentals. Freeport- McMoRan has significant levels of exposure to a few...
FCX: 26.43 (-0.27)

Feasting On The Stock Market Harvest
Eric Parnell, CFA - Seeking Alpha - Fri Nov 28, 1:55AM CST
The day of fortune is like a harvest day We must be busy when the corn is ripe - Torquato Tasso Americans celebrated the Thanksgiving holiday this Thursday with people across the country coming together to feast and give thanks. Many...
NBL: 51.58 (-0.56), FCX: 26.43 (-0.27), XOM: 94.37 (-0.58), GOOG: 537.31 (+5.99), TLT: 121.80 (+1.01), EEM: 40.96 (+0.07), COH: 34.70 (-0.39), SPY: 207.66 (-0.23), RIG: 18.68 (-0.89), IBM: 164.05 (-0.47), MAT: 30.68 (+0.41), BHP: 51.24 (-0.48), OIL: 16.05 (-0.19), APA: 63.25 (-1.05), XLK: 42.17 (unch), GOOGL: 542.58 (+5.61), OXY: 82.54 (-0.56), VNQ: 81.00 (+0.21), JJC: 35.14 (+0.57), EPP: 46.07 (-0.01), XLE: 81.25 (-0.71), AMZN: 316.93 (+0.43), XLY: 71.37 (-0.04), XLU: 46.23 (-0.04), IEV: 44.68 (-0.18), GM: 33.09 (-0.55), CVX: 112.28 (-1.43)

I'm Thankful for Lower Share Prices
Jim Mueller, The Motley Fool - Motley Fool - Wed Nov 26, 10:16AM CST
Four years into the Messed-Up Expectations portfolio and, as I reviewed here , I'm doing all right. I've twice met my goal of generating 15% annually on rolling three-year periods, and I'm on pace to do it again. Assuming, that is, that the hit...
TRN: 31.61 (-0.13), FCX: 26.43 (-0.27), MBLY: 43.48 (+1.67)

Improved Commodity Prices Should Spur Freeport-McMoRan
Michael Swanson - Seeking Alpha - Wed Nov 26, 9:35AM CST
Freeport-McMoran (NYSE: FCX ), the Arizona-based copper, gold and molybdenum mining company with assets in North America, South America, Indonesia and Africa, has been affected by the recent fall in commodity prices. The impact of commodity prices...
FCX: 26.43 (-0.27)

Watch for Shares of Freeport-McMoRan (FCX) to Approach Resistance at $29.57
Comtex SmarTrend(R) - Wed Nov 26, 9:29AM CST
Shares of Freeport-McMoRan (NYSE:FCX) opened today above their pivot of $29.24 and have already reached the first level of resistance at $29.42. Should the shares continue to rise, the resistance pivots of $29.57 and $29.90 will be of interest.
FCX: 26.43 (-0.27)

10 Prize Bad-Boy Dividend Dogs Do 13% To 31% November Upsides
Fredrik Arnold - at Seeking Alpha - Wed Nov 26, 8:40AM CST

NMFC: 15.05 (unch), COT: 6.59 (-0.02), FCX: 26.43 (-0.27), PER: 7.56 (-0.34), EROC: 2.80 (-0.04), WIN: 9.71 (-0.12), UAN: 10.30 (-0.17), DRI: 57.85 (-0.26), OCIP: 16.86 (-0.19), FSC: 8.58 (+0.05), APL: 30.38 (-0.13), SXE: 14.06 (-0.68), JE: 4.97 (-0.10), OB: 16.05 (+0.11), PSEC: 8.89 (-0.19), SUN: 46.48 (+0.07)

'Mad Money' Lightning Round: Alcoa Is Getting Stronger and Going Higher
at The Street - Wed Nov 26, 5:00AM CST
Cramer wants no part of Advanced Micro Devices or Freeport-McMoRan but likes Alliant Techsystems and Enterprise Products Partners.
HAS: 56.75 (-0.33), AA: 17.24 (+0.03), SWKS: 69.75 (+3.08), AMD: 2.69 (-0.05), FCX: 26.43 (-0.27), INTC: 37.46 (+0.03), ATK: 110.36 (+0.02), EPD: 38.14 (-0.03), LF: 5.13 (+0.01)

Cramer's Lightning Round - Enterprise Products Partners Is In The Catbird Seat (11/25/14)
SA Editor Miriam Metzinger - at Seeking Alpha - Wed Nov 26, 3:29AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Tuesday November 25. Bullish Calls: Enterprise Products Partners (NYSE: EPD ): "What a horse. That stock is a winner. I like that 3-plus yield. Plus...
HAS: 56.75 (-0.33), AA: 17.24 (+0.03), SWKS: 69.75 (+3.08), AMD: 2.69 (-0.05), FCX: 26.43 (-0.27), ATK: 110.36 (+0.02), INTC: 37.46 (+0.03), EPD: 38.14 (-0.03), LF: 5.13 (+0.01)

Jim Cramer's 'Mad Money' Recap: Who Needs the Fed When U.S. Has Growth and Profits?
at The Street - Tue Nov 25, 7:08PM CST
U.S. GDP grew by 3.9%, the fastest back-to-back quarters in over three years and proof the market's rally is backed by higher corporate profits and confident consumers, Cramer says.
HAIN: 114.07 (+1.59), HAS: 56.75 (-0.33), AA: 17.24 (+0.03), SWKS: 69.75 (+3.08), AMD: 2.69 (-0.05), FCX: 26.43 (-0.27), PLAY: 23.71 (+0.45), INTC: 37.46 (+0.03), ATK: 110.36 (+0.02), AAPL: 115.49 (-0.44), EPD: 38.14 (-0.03), LF: 5.13 (+0.01)

Market Maker Surveillance Report. PFE, FCX, EMC, T, HAL, BTU, Bearishly Biased Price Friction For Monday, November 24th 2014
M2 - Tue Nov 25, 3:28AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Monday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Monday there were 4529 companies with "abnormal" market making, 2852 companies with positive Friction Factors and 2227 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bearish bias) in their stock prices. This means that there was more buying than selling in the stocks and their stock prices dropped. Pfizer Inc (NYSE FE), Freeport-McMoRan Copper & Gold Inc (NYSE:FCX), EMC Corp (NYSE:EMC), AT&T Inc (NYSE:T), Halliburton Co (NYSE:HAL), Peabody Energy Corp (NYSE:BTU). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
T: 33.91 (-0.09), BTU: 8.88 (-0.31), FCX: 26.43 (-0.27), PFE: 31.67 (-0.08), HAL: 40.74 (-0.01), EMC: 30.32 (+0.01)

3 Hold-Rated Dividend Stocks: FCX, MMLP, NYMT
at The Street - Mon Nov 24, 9:31AM CST
These 3 dividend stocks are rated a Hold by TheStreet
MMLP: 33.46 (-0.74), FCX: 26.43 (-0.27), NYMT: 7.97 (-0.08)

Comparing North America's 3 Largest Copper Companies
Joseph Cafariello - at Seeking Alpha - Mon Nov 24, 8:17AM CST

SCCO: 30.02 (+0.17), FCX: 26.43 (-0.27), NSU: 3.77 (-0.16)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 5

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading

Top 5 Most Recently Viewed Articles

BioCryst Pharmaceuticals Reports Positive Outcomes for ORLADEYO

Updated Category News Views 62

BioCryst Pharmaceuticals Highlights ORLADEYO's Impact BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) has unveiled a compelling study that underscores how ORLADEYO (berotralstat) significantly lowers healthcare resource utilization (HRU) for patients battling hereditary angioedema (HAE). This innovative oral treatment has garnered attention due to its remarkable findings,...

Continue Reading
Man Group PLC Discloses Interest in Spectris plc Shares

Updated Category News Views 174

Understanding Man Group PLC's Position Disclosure Man Group PLC is making headlines as it officially discloses its holdings in Spectris plc. This disclosure is known as FORM 8.3 and is a crucial document under Rule 8.3 of the Takeover Code. It indicates the shareholding interests of Man Group in Spectris, representing a significant percentage of the company's relevant...

Continue Reading
Centessa Pharmaceuticals Seeks $225 Million Through Public Offering

Updated Category News Views 91

Centessa Pharmaceuticals Launches Major $225 Million Offering Centessa Pharmaceuticals plc (NASDAQ: CNTA), an innovative clinical-stage pharmaceutical company, has announced an ambitious public offering with the goal of raising around $225 million. This offering features 15,254,237 American Depositary Shares (ADSs), each representing one ordinary share, priced at $14.75...

Continue Reading
Unveiling Software Giants: Microsoft and Its Rivals in 2024

Updated Category News Views 350

Understanding the Competitive Landscape of Software Giants In the dynamic world of software, staying informed about leading companies is vital for investors and analysts alike. This article focuses on Microsoft (NASDAQ: MSFT) and its primary competitors, aiming to deliver a thorough analysis of financial statistics, market standings, and opportunities for growth within...

Continue Reading
Harris Leads Trump by 3 Points in Key Election Polls

Updated Category News Views 105

Election Polls Show Harris's Slim Lead Over Trump In the battleground of the upcoming U.S. presidential election, Democratic Vice President Kamala Harris has established a slender lead over Republican contender Donald Trump, according to the latest polling data. Recent surveys indicate that Harris is ahead by a margin of 3 points, with her support reaching 45% compared to...

Continue Reading